KRRO

Korro Bio, Inc.

Latest Form 4:Sale$4KbyFORMELA JEAN FRANCOIS (Director) · filed Aug 28, 2026

Korro Bio, Inc. (KRRO) has 34 SEC Form 4 filings (49 transaction rows) in the rolling window, disclosed by 16 distinct insiders. Most recent filing: Aug 28, 2026.

The most active filer is Director FORMELA JEAN FRANCOIS with 9 filings. Insiders have net bought $15.9M over the trailing 6 months. The largest single insider purchase in this window was $2.3M by 10% Owner BASKETT FOREST on Mar 10, 2026.

  • Industry:Biotechnology
  • CEO:Ram Aiyar
  • Employees:49
  • HQ:Cambridge, MA, US
  • IPO:2019-10-03

Insider Buying

$20.8M

reported purchases (SEC code P)

Insider Selling

$4.9M

reported sales (SEC code S)

Unique Insiders

16

in the rolling window

Market Cap

$190.1M

latest known value

Source
Sale$4KAug 28SEC ↗
Sale$399KAug 21SEC ↗
Purchase$60KAug 13SEC ↗
Purchase$19KAug 13SEC ↗
Sale$30KAug 13SEC ↗
Sale$63KAug 5SEC ↗
Sale$1.4MJul 7SEC ↗
Sale$130KJul 7SEC ↗
Sale$55KJun 25SEC ↗
Sale$1.7MJun 25SEC ↗
Sale$707KJun 25SEC ↗
Chappell ToddFirst filing
Sale$34KJun 17SEC ↗
Dolan OliverFirst filing
Sale$37KJun 17SEC ↗
Vincent Loic AFirst filing
Sale$37KJun 17SEC ↗
Cerio JeffreyFirst filing
Sale$72KJun 17SEC ↗
Aiyar RamFirst filing
Sale$197KJun 2SEC ↗
Sale$40KJun 1SEC ↗
Purchase$6KApr 2SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗
Purchase$2.3MMar 12SEC ↗

Related companies

Korro Bio, Inc. is in the Healthcare sector.